Product Description: Conteltinib (CT-707) is a multi-kinase inhibitor targeting FAK, ALK, and Pyk2. Conteltinib exerts significant inhibitory effect on FAK with an IC50 of 1.6 nM[1].
Applications: Cancer-Kinase/protease
Formula: C32H45N9O3S
References: [1]Wang DD, et al. CT-707, a Novel FAK Inhibitor, Synergizes with XL184 to Suppress Hepatocellular Carcinoma by Blocking XL184-Induced FAK Activation. Mol Cancer Ther. 2016 Dec;15(12):2916-2925.
CAS Number: 1384860-29-0
Molecular Weight: 635.82
Compound Purity: 99.0
Research Area: Cancer
Solubility: DMSO : 31.25 mg/mL (ultrasonic)
Target: FAK